Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIBIB NIH HHS
Grant: R01 EB023924
NCI NIH HHS
Grant: R21 CA252370
National Institutes of Health
Grant: 5R01EB023924-02
Development of a New Fluorescent Agent for Intraoperative Image-Guided Breast Cancer Surgery
National Institutes of Health
Grant: 1R21CA252370-01
MicroRNA Targeted Therapeutic Approach for Pediatric High-Grade Glioma
FWCI
1.25
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals